Safety data on AstraZeneca anemia drug points to potential use in dialysis

AstraZeneca said on Friday that safety data on roxadustat underpinned the British drugmaker's hopes for the anemia drug to become a standard treatment for patients with kidney disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news